Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
35.85
-1.98 (-5.22%)
Mar 31, 2025, 10:11 AM EDT - Market open

Ultragenyx Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
560.23434.25363.33351.41271.03
Upgrade
Revenue Growth (YoY)
29.01%19.52%3.39%29.66%161.32%
Upgrade
Cost of Revenue
774.59693.66734.11513.16418.21
Upgrade
Gross Profit
-214.36-259.41-370.78-161.76-147.18
Upgrade
Selling, General & Admin
321.61309.8278.14219.98182.93
Upgrade
Operating Expenses
321.61309.8278.14219.98182.93
Upgrade
Operating Income
-535.97-569.21-648.92-381.74-330.12
Upgrade
Interest Expense
-63.04-66-43.02-29.42-33.29
Upgrade
Interest & Investment Income
36.5126.6911.071.937.04
Upgrade
Other Non Operating Income (Expenses)
-3.96-0.34-1.57-1.690.61
Upgrade
EBT Excluding Unusual Items
-566.47-608.86-682.43-410.92-355.76
Upgrade
Gain (Loss) on Sale of Investments
-1.120.4-19.3-42.06170.4
Upgrade
Pretax Income
-567.59-608.46-701.73-452.98-185.36
Upgrade
Income Tax Expense
1.6-1.835.71.041.21
Upgrade
Net Income
-569.18-606.64-707.42-454.03-186.57
Upgrade
Net Income to Common
-569.18-606.64-707.42-454.03-186.57
Upgrade
Shares Outstanding (Basic)
9174706861
Upgrade
Shares Outstanding (Diluted)
9174706861
Upgrade
Shares Change (YoY)
23.11%5.19%3.13%11.42%7.54%
Upgrade
EPS (Basic)
-6.29-8.25-10.12-6.70-3.07
Upgrade
EPS (Diluted)
-6.29-8.25-10.12-6.70-3.07
Upgrade
Free Cash Flow
-421.68-519.07-496.59-411.79-176.13
Upgrade
Free Cash Flow Per Share
-4.66-7.06-7.10-6.07-2.90
Upgrade
Gross Margin
-38.26%-59.74%-102.05%-46.03%-54.31%
Upgrade
Operating Margin
-95.67%-131.08%-178.60%-108.63%-121.80%
Upgrade
Profit Margin
-101.60%-139.70%-194.70%-129.20%-68.84%
Upgrade
Free Cash Flow Margin
-75.27%-119.53%-136.68%-117.18%-64.98%
Upgrade
EBITDA
-500.43-543.2-630.7-368.5-317.86
Upgrade
EBITDA Margin
-89.33%-125.09%-173.59%-104.86%-117.28%
Upgrade
D&A For EBITDA
35.5426.0118.2213.2412.26
Upgrade
EBIT
-535.97-569.21-648.92-381.74-330.12
Upgrade
EBIT Margin
-95.67%-131.08%-178.60%-108.63%-121.80%
Upgrade
Revenue as Reported
560.23434.25363.33351.41271.03
Upgrade
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q